And this naturally makes sense: research shows that 88% of consumers would switch to a competitor after three (or even fewer) bad experiences. However, as noted in the article we’d like to share, transitioning toward a customer-centric focus requires a shift not in the business model itself, but in the way of thinking—that is, in the mindset.
A customer-centric approach is about understanding that the ideal outcome "is not just business growth, but customer happiness, or at least improving the user experience (UX)—recognizing that if the latter is sought and achieved, the former will naturally follow, making the transformation worthwhile on all fronts."
This article reviews an example from the pharmaceutical sector: the Infinity model, a pilot program by the pharmaceutical company Roche. "Its most visible difference from standard customer centricity proposals lies in the architecture of the company’s relationship with the customer. Rather than a traditional hierarchy, it establishes a framework that integrates the company directly into the self-organized networks of individuals," the article highlights.
User Experience Design
This company's model seeks to empower patients by redefining how it connects with them and their key stakeholders. Originally organized around reinventing care for individuals with rare, life-threatening diseases, the initiative addresses patients facing overwhelming challenges. Beyond the physical, emotional, mental, and financial demands of living with their condition, "they also suffer daily from a lack of support within the healthcare system they rely on."
These patients require far more than medication: they need awareness of and opportunities to participate in clinical trials, affordable treatment, and trained support teams capable of helping them navigate the complex hurdles posed by their conditions.
To build a more holistic, patient-centered care ecosystem, Roche devised a disruptive innovation: creating a specialized team known as Rare Condition Partners (RCPs). This group consists of liaisons who embed themselves within patient communities. In other words, "they connect patients with healthcare providers, patient advocacy groups, and care networks within Roche, fostering a proactive environment that empowers everyone involved to co-create solutions."
Freed from the constraints of traditional hierarchies, bureaucracy, and transactional business models, more than 120 RCPs worldwide "provide support that extends beyond securing suitable drug trials to co-creating creative strategies tailored to patients' needs." By identifying pain points and joining forces with partners outside the healthcare industry to solve them, "RCPs inspire the community to find fresh, disruptive solutions," as the text explains.
In addition to bridging Roche with patient communities, RCPs connect these communities with one another, building powerful, agile networks.
Innovative Projects
Not all RCP solutions rely on advanced technology or medicine—some simply demand empathy and ingenuity. Furthermore, the sense of purpose derived from working in genuinely collaborative partnerships attracts passionate employees who drive an entrepreneurial, experimental approach to patient-centered care.
This patient-centric method represents a biopharmaceutical-specific adaptation of the broader customer-centric model. It holds broad application potential across sectors for innovative companies pioneering a service level that prioritizes customer outcomes over revenue—ultimately elevating both.
Ultimately, driving customer centricity in innovative companies doesn't require a new model; it demands a new mindset.
To learn more about this customer centricity case study, you can access the following link.